Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1991
Generation of monoclonal antibodies to murine IL-1 beta and demonstration of IL-1 in vivoK A Hogquist, M A Nett, K C Sheehan, et al.Journal of Virology|July 1, 1992
Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like proteinM Shirai, T Akatsuka, C D Pendleton, et al.Science (New York, N.Y.)|January 17, 1992
Induction of broadly cross-reactive cytotoxic T cells recognizing an HIV-1 envelope determinantH Takahashi, Y Nakagawa, C D Pendleton, et al.The Journal of Clinical Investigation|September 17, 1998
Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positionsP Sarobe, C D Pendleton, T Akatsuka, et al.Journal of Virology|January 1, 1996
Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 regionK Kurokohchi, T Akatsuka, C D Pendleton, et al.The Journal of Clinical Investigation|September 1, 1991
Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC typesJ A Berzofsky, C D Pendleton, M Clerici, et al.Cancer Research|July 15, 1993
A mutant p53 tumor suppressor protein is a target for peptide-induced CD8+ cytotoxic T-cellsM Yanuck, D P Carbone, C D Pendleton, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1996
Reciprocal cytotoxic T lymphocyte cross-reactivity interactions between two major epitopes within HIV-1 gp160M Shirai, K Kurokohchi, C D Pendleton, et al.Biochemistry and Biophysics Reports|November 11, 2017
Chromatin structure analysis enables detection of DNA insertions into the mammalian nuclear genomeChallise J Sullivan, Erik D Pendleton, Rachel E Abrams, et al.The Journal of Experimental Medicine|June 1, 1992
Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I moleculesS Kozlowski, M Corr, T Takeshita, et al.Pageof 5